Anglonordic is the only life science conference in the UK that is exclusively for European investors and R&D companies from the Nordics and the UK to connect with each other. With an established format of panel discussions, parallel technology and biotech investment rooms, plus 1:1 meetings, this 1-day London conference provides exceptional value. Investors with funds attend free-of-charge.
MEET decision makers at leading and upcoming drug discovery and technology companies from the UK and Nordic regions, along with investment firms from throughout Europe
LEARN from major investment firms about the current status of European investment in life science technologies
GAIN insights from experienced life science operators within the Anglo-Nordic space
The Anglonordic Life Science Conference has a “by-invitation-only” policy. The organisers welcome a limited number of service suppliers as sponsors or exhibitors.
The main conference room has a biotech investment focus; the technology room features devices, diagnostics, delivery and development tools. One-to-one meetings take place throughout the day. The Exhibition and quiet area double up for lunch service and refreshments are available all day.
One-to-one partnering meetings are pre-booked using the globally-renowned Meeting Mojo booking platform. Registered delegates can log in to browse profiles, set their own availability, request meetings, and promote their company to best advantage.
Networking begins on the evening before the conference with an exclusive Reception in Central London, free of charge to all registered delegates.
Applications for presentation slots are being accepted by emailing email@example.com. DO NOT register here for delegate, sponsor, or exhibitor passes - instead follow the link in your invitation or request an invitation here.
Gold and Partnering Sponsors
Organisations registered to attend include:
Investors: 4BIO Capital, Abingworth, Advent Life Sciences, Albion Technology & General VCT, Anvil Partners, Arix Bioscience, Arrowfield Capital, Axilium Capital, Bioscience Managers, BioSeed Capital, Bridge Valley Ventures, Catapult Ventures, DeBere Capital Partners, Deltec International Group, FastVentures, Glentworth Ventures, Helsinn Investment Fund, Ignite Capital Partners, Industrifonden, INKEF Capital, Inkef Capital, Innovator Capital, Inventages Venture Capital, Investor Corporat, IPF Partners, Julz Co, Longacre Funding partners, LSP, M Ventures, Masselos Family Office, MEDICXI, Mercia Technologies, Molecular Warehouse, Momentum Biotech, National Institute for Health Research, NCL Technology Ventures, New Science Fund, Norgine Ventures, Novo Seeds, Novo Ventures, NVM, Optum Ventures, Panakes Partners, Rothschild, S.R.One, Seroba Life Sciences, Seventure, Silicon Valley Bank, Sofinnova, Start Codon, Sunstone Life Science Ventures, UKI2S, Velocity Fund Partners, Vivanova , W Global Capital Limited, YSIOS CAPITAL
Delegates: Abbvie, AstraZeneca, Bayer, Eli Lilly, Johnson and Johnson Innovation, Merck, Otsuka Europe, 20one Clinic, Ablatus Therapeutics , Acesion Pharma, Acrus Altor, Adenium Biotech, Antagonis, Apitope, Arterial Capital Management, Artios Pharma, Asceneuron, Athena Market Access Solutions, AVILLION, BioCentury Publications, BioPartner UK, Biotec PharmaconA, BTG, Calliditas, Censo Biotechnologies , CMR Surgical, COMPASS Pathways, Cumulus Oncology , Department for International Trade, Drug Discovery Today, Embassy of Spain in London, EP Vantage, Eurofins Amatsigroup, Evox Therapeutics, Ezenze, F2G, Fusion Antibodies, GenYX, GGS Associates, Global Regulatory Services, ImaginAB, International Biotechnology Trust, Invest in Denmark, Embassy of Denmark, ISA Therapeutics, J A Kemp, Jefferies, Labiotech.eu, Lavivo, Locust Walk, London Business School, LSX, Masters Speciality Pharma, Medherant, Medicon Valley Alliance, MediSieve Limited, Medopad, Meeting Mojo, Mission Therapeutics, Nature Biotechnology, One Nucleus, Optimum Strategic Communications, Oxford Cardiomox , Parkinson’s Concierge , PCI Clinical Services, Pebmond Associates, Prophylix, Public Health England, RDP Life Sciences, ReNeuron , River Stone, RTC S.p.A., RYSE Asset Management, Sartar Therapeutics, Scrip, Silicon Valley Bank, Sygnature Discovery, UK BioIndustry Association (BIA), University of Dundee, Valirx, Vantage, VAXIMM, William Reed, Zerion APS.